TL;DR
This study maps the transcriptomic and epigenetic changes in lung endothelial cells (ECs) as they transition from an active state in infants to a quiescent state in adult mice. They discovered that this transition is driven by coordinated changes in gene expression and DNA methylation, particularly involving the TGF-beta signaling pathway, and identified specific genes (SMAD6 and SMAD7) that play a crucial role in maintaining vascular quiescence.
What Problem Does This Paper Address?
Maintaining a stable, non-dividing layer of endothelial cells (ECs) lining blood vessels, known as vascular quiescence, is essential for overall health. When this quiescent state is lost, it can lead to various diseases like atherosclerosis, stroke, and cancer. While we understand a lot about EC activation and angiogenesis (the formation of new blood vessels), the molecular mechanisms that maintain vascular quiescence have remained largely unclear. This paper aims to fill that knowledge gap by providing a comprehensive, genome-wide view of the transcriptional and epigenetic landscape associated with the acquisition and maintenance of EC quiescence.
Methods
The researchers employed a multi-omics approach to compare lung ECs from infant (actively growing vasculature) and adult (quiescent vasculature) mice. Key techniques included:
- RNA-sequencing (RNA-seq): To profile the gene expression (transcriptome) in both infant and adult ECs.
- Tagmentation-based Whole Genome Bisulfite Sequencing (T-WGBS): A high-resolution method to map DNA methylation patterns across the entire genome. This technique allows for the identification of changes at single CpG sites.
- Comparative Transcriptome Analysis: Identifying genes that are significantly up- or down-regulated between the two age groups.
- Interactome Analysis: Building protein-protein interaction networks to understand how differentially expressed genes function together.
- Functional Annotation: Using tools like Reactome and GREAT to identify enriched biological pathways and functions associated with the observed gene expression and methylation changes.
- In vitro functional experiments: Using human umbilical vein endothelial cells (HUVECs) to experimentally validate the role of key identified genes (SMAD6 and SMAD7) in regulating EC behavior (proliferation, migration, viability).
Datasets
The study generated and analyzed two primary datasets:
- Lung EC transcriptomic data: RNA-seq data from FACS-sorted lung ECs of infant and adult mice.
- Lung EC DNA methylome data: T-WGBS data from FACS-sorted lung ECs of infant and adult mice.
Previously published datasets were also utilized for functional annotation and comparative analysis, including data from the Mouse ENCODE Consortium and other studies on cis-regulatory sequences.
Key Insights and Ideas
- TGF-beta signaling is a key regulator of quiescence: The study strongly implicates the TGF-beta signaling pathway as a central player in the transition to vascular quiescence, showing a coordinated downregulation of pro-angiogenic components and upregulation of inhibitory SMAD proteins.
- Intronic enhancers are dynamically regulated epigenetically: A significant finding is the prominent loss of DNA methylation in intronic regions, specifically within putative enhancer regions, which correlates with increased gene expression. This highlights the importance of non-coding regulatory elements in controlling quiescence.
- SMAD6 and SMAD7 are critical epigenetic regulators: The research identifies SMAD6 and SMAD7, known inhibitors of TGF-beta signaling, as being epigenetically regulated (specifically, hypomethylated and upregulated in adult ECs) and demonstrates their direct role in promoting EC quiescence through in vitro experiments.
- Quiescence is an active process, not just an absence of activation: The findings suggest that maintaining quiescence involves a dynamic interplay of activating and inhibiting pathways, rather than simply shutting down pro-angiogenic signals.
Key Results
- Transcriptomic changes: 2,216 differentially expressed genes were identified between infant and adult lung ECs. These included downregulation of cell cycle and developmental angiogenesis genes, and upregulation of immune system and metabolism genes.
- Epigenetic changes: A global increase in CpG methylation was observed in adult ECs compared to infant ECs. More specifically, a prominent loss of DNA methylation was found in intronic enhancer regions.
- TGF-beta pathway inhibition: The TGF-beta signaling pathway was identified as the most significantly inhibited pathway in quiescent ECs, with downregulation of receptors and upregulation of inhibitory SMADs (SMAD6 and SMAD7).
- SMAD6 and SMAD7 validation: Overexpression of SMAD6 and/or SMAD7 in HUVECs led to reduced SMAD phosphorylation, decreased cell viability, proliferation, and migration, confirming their role in promoting quiescence.
- VEGF pathway neutrality: Notably, the VEGF pathway, a master regulator of angiogenesis, was not significantly differentially regulated transcriptionally or epigenetically during the transition to quiescence, suggesting its role might be more context-dependent or related to survival rather than active proliferation control in this specific scenario.
Limitations and Future Work
- Focus on lung ECs: While the findings are likely applicable to other vascular beds, the study primarily focused on lung ECs. Future work could explore if these mechanisms are conserved across different tissue types.
- Mechanistic details of intronic enhancers: The precise mechanisms by which intronic enhancer methylation influences gene expression require further detailed investigation.
- Therapeutic potential: The authors suggest that understanding these mechanisms could pave the way for novel therapeutic strategies to target unwanted EC activation in diseases. Future research could explore how to therapeutically manipulate these pathways to restore or maintain vascular quiescence.
- VEGF dynamics: While VEGF signaling wasn't a primary driver of quiescence in this study, its specific regulation (e.g., increased VEGFA in adult ECs, altered VEGFR1/VEGFR2 ratio) warrants further investigation into its role in maintaining homeostasis.
Summary updated